Priscila Gonçalves - Concepedia

Author

Priscila Gonçalves

Also Known As

P. Goncalves, P. Gonçalves, P. H. Goncalves, P.H. Gonçalves, P.H.B. Goncalves, Plínio E.S. Gonçalves, Priscila Goncalves, Priscila Gonçalves, Priscila H Goncalves, Priscila H. Goncalves

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research Frederick National Laboratory for Cancer Research Leidos (United States)National Institutes of Health

About

Priscila Gonçalves is an author at National Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	338
2	Health Sciences	2	2	24
3	Cell Biology	2	2	216
4	Immunology	2	2	59
5	Microbiology	1	1	48

Priscila Gonçalves

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay, JAMA Oncology	2019	220
Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Shaan Sarkar, Hala Dubaybo, Shadan Ali, PubMed Cancer ResearchOncologyPancreatic CancerMedicineSynthetic Curcumin Analogue	2013	170
Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data Priscila Gonçalves, Stephanie Peterson, Fawn D. Vigneau, Cancer	2016	143
Viral, immunologic, and clinical features of primary effusion lymphoma Kathryn Lurain, Mark N. Polizzotto, Karen Aleman, Blood	2019	130
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill, Journal of Clinical Oncology	2016	129
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy Thomas S. Uldrick, Scott V. Adams, Rémi Fromentin, Science Translational Medicine	2022	97
Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases Ramya Ramaswami, Kathryn Lurain, Mark N. Polizzotto, Blood Advances	2021	68
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma Priscila Gonçalves, Lance K. Heilbrun, Michael T. Barrett, Oncotarget	2017	67
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan, Journal for ImmunoTherapy of Cancer	2021	56
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease Ramya Ramaswami, Kathryn Lurain, Cody J. Peer, Blood	2020	49

Page 1